Everolimus in Treating Patients With Stage IV Melanoma

NCT00098553 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

53

Enrollment

OTHER

Sponsor class

Conditions

Melanoma (Skin)

Interventions

DRUG: everolimus

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]